ALXO icon

ALX Oncology

108 hedge funds and large institutions have $780M invested in ALX Oncology in 2021 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less funds holding

Funds holding:

less first-time investments, than exits

New positions opened: | Existing positions closed:

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

48% less call options, than puts

Call options by funds: $262K | Put options by funds: $503K

69% less capital invested

Capital invested by funds: $2.55B → $780M (-$1.77B)

Holders
108
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$262K
Puts
$503K
Net Calls
Net Calls Change

Top Buyers

1 +$28.7M
2 +$12.5M
3 +$8.3M
4
PC
Pier Capital
Connecticut
+$4.85M
5
Morgan Stanley
Morgan Stanley
New York
+$3.72M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$570K
52
$527K
53
$520K
54
$505K
55
$485K
56
$468K
57
$462K
58
$441K
59
$421K
60
$412K
61
$403K
62
$387K
63
$380K
64
$372K
65
$354K
66
$340K
67
$333K
68
$326K
69
$312K
70
$306K
71
$297K
72
$276K
73
$247K
74
$246K
75
$245K